BLOOMINGTON, Minn.--(BUSINESS WIRE)--SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, today announced that company management is scheduled to participate in four upcoming investor conferences taking place during the third quarter: Needham Virtual Semiconductor & SemiCap 1x1 Conference August 21, 2025 Jefferies Semiconductor, IT Hardware & Communications Technology Conference Four Seasons Chicago August 27, 2025 B. Riley Securities Annual Consumer & TMT.

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)-- #tech--Perion Network Ltd. (NASDAQ and TASE: PERI), a leader in advanced technology solving for the complexities of modern advertising, today reported its financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights1 In millions, except per share data Three months ended Six months ended June 30, June 30, 2025 2024 % 2025 2024 % Advertising Solutions Revenue $ 80.6 $ 74.4 8% $ 150.3 $.

Board accepts Zachary Bradford's resignation as chief executive officer and director of CleanSpark LAS VEGAS , Aug. 11, 2025 /PRNewswire/ -- CleanSpark, Inc. (Nasdaq: CLSK) (the "Company"), America's Bitcoin Miner®, has named Matt Schultz, co-founder, executive chairman and former CEO of CleanSpark as CEO, effective immediately following the resignation of Zachary Bradford as an officer and director of the Company. Schultz founded CleanSpark and previously served as CEO and is currently Executive Chairman.

Fed officials signal possible rate cuts this year, boosting the appeal of growth-focused ETFs amid slowing labor market trends. Tap ETFs like VUG, RPG and VOOG.

As a result of the changing EV landscape under President Donald Trump, U.S. automakers are evaluating their product lineups and calculating the dollar impacts. Tesla CEO Elon Musk said during the automaker's latest earnings call that the company is in a "weird transition period" as it deals with losing EV incentives in the U.S.

BEDFORD, Mass., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine, and Biogen Inc. (Nasdaq: BIIB), today announced that the first patient has been dosed in the global Phase 3 EMPEROR study of zorevunersen for the treatment of Dravet syndrome. Zorevunersen, an investigational antisense oligonucleotide, has the potential to be the first disease-modifyi.

OTTAWA, ON , Aug. 11, 2025 /PRNewswire/ -- Senstar Technologies Corporation (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security products and solutions, will report financial results for its second quarter ended June 30, 2025, on Monday, August 25, 2025. Management will conduct a conference call to review the Company's financial results at 5:00 p.m.

Cash, cash equivalents, marketable securities and restricted cash as of June 30, 2025, totaled approximately $408.2 million VYGLXIA NDA for spinocerebellar ataxia (SCA) PDUFA date 4Q2025, completed clinical trial inspections by FDA without observations or findings, and filing review remains ongoing MoDE and TRAP degrader platforms advance in clinical development, IgG reductions of up to 87% observed with MoDE degrader BHV-1300 in Phase 1 with the potential to address IgG-mediated diseases including Graves' disease and rheumatoid arthritis; sustained and deep Gd-IgA1 reductions over 80% reported with TRAP degrader BHV-1400 highlight its potential for treating IgA Nephropathy Next -generation Trop2 Antibody …

NEW HAVEN, Conn., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D.

Announced positive Phase 1 data for SION-719 and SION-451 demonstrating both first-in-class NBD1 stabilizers were generally well tolerated and exceeded pharmacokinetic targets Initiation of Phase 2a proof-of-concept trial of SION-719 as an add-on to standard of care in cystic fibrosis patients is on track for the second half of 2025 with topline data expected in mid-2026 Advancement of Phase 1 healthy volunteer trial of SION-451 in two proprietary dual combinations is on track for the second half of 2025 with topline data expected in mid-2026 Maintained strong cash position with approximately $337.3 million in cash and cash equivalents, expected to …

AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES HOUSTON , Aug. 11, 2025 /PRNewswire/ -- Today Western Midstream Partners, LP (NYSE: WES) ("WES" or the "Partnership") announced that tomorrow before the market open it will make available on its website at www.westernmidstream.com a post-earnings interview with Kristen Shults, Senior Vice President and Chief Financial Officer, and Jon VandenBrand, Senior Vice President, Commercial, that provides additional insights related to WES's second-quarter 2025 results. In addition, WES intends to participate in the following investor conferences during the third and fourth quarters of 2025: Citi's 2025 Natural Resources Conference in Las Vegas, Nevada on August …

Q2 Highlights (All comparisons are year-over-year, unless otherwise noted) Operations impacted by ERP roll out and supply constraints Net sales down 0.6% to $311.6 million GAAP diluted EPS of $0.19 down 69.4% and Non-GAAP adjusted diluted EPS of $0.22 down 64.5% Non-GAAP Adjusted EBITDA margin down 1,120 basis points to 14.9% Strong bookings trends of both AAON- and BASX-branded equipment points to share gains continuing Adjusted backlog up year-over-year 71.9% to $1.12 billion Reducing full-year 2025 outlook TULSA, Okla. , Aug. 11, 2025 /PRNewswire/ -- AAON, INC.

OMAHA, NE, Aug. 11, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that on August 8, 2025, it successfully closed the acquisition of substantially all of the assets of Irwin Naturals and its related affiliates (“Irwin”) as previously approved by the US Bankruptcy Court for the Central District of California. Through the asset purchase transaction under Section 363 of the US Bankruptcy Code, the Company acquired substantially all of the assets and assumed minimal liabilities of Irwin.

- Total revenues of $301,000 for quarter, and $818,000 for first six months of 2025, from sales and collaborative research agreement - - 82 civilian hospitals now have VAC approval to purchase Symvess™ - - ECAT approval makes Symvess available to 35 Military Treatment Facilities and 160 U.S. Department of Veterans Affairs hospitals - - Conference call today at 8:00 am ET - DURHAM, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced financial results for the second quarter ended June 30, …

Premium Screens Worldwide Take Advantage of Pixelworks' Award-Winning Motion Technology Universal Pictures' "Nobody 2" arrives in theaters August 15, 2025 LOS ANGELES , Aug. 11, 2025 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), announced today that Universal Pictures' Nobody 2 will be presented with TrueCut Motion™ technology on selected premium screens worldwide. Under the direction of the filmmakers, the Pixelworks motion grading team utilized advanced TrueCut Motion technology to bring stunning motion clarity to the new chapter from the bare-knuckle action-thriller, Nobody, which opened at number one at the box office in 2021.

AKRON, Ohio , Aug. 11, 2025 /PRNewswire/ -- BIT Mining Limited (NYSE: BTCM) ("BIT Mining" or the "Company"), a leading technology-driven cryptocurrency infrastructure company, today announced that it plans to release its unaudited financial results for the second quarter ended June 30, 2025, after the U.S. market close on Thursday, August 14, 2025. About BIT Mining Limited BIT Mining Limited (NYSE: BTCM) is a technology-driven cryptocurrency asset company that is strategically transitioning its core business toward Solana ("SOL") treasury operations.

Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by Operations Third Quarter 2025 Guidance Reflects Improved Operations and Strong Financial Discipline New Credit Amendment Signed, Extending Refinance Deadline to December 5th HOLLISTON, Mass., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2025.

Appoints 25-Year OpenText Veteran James McGourlay as Interim Chief Executive Officer Board of Directors Establishes Executive Committee and Commences CEO Search Company to Continue to Explore Portfolio-Shaping Opportunities to Enhance Focus WATERLOO, ON , Aug. 11, 2025 /PRNewswire/ -- Open Text Corporation (NASDAQ: OTEX) (TSX: OTEX) ("OpenText" or the "Company") today announced the appointment of James McGourlay, currently Executive Vice President, International Sales at OpenText, as Interim Chief Executive Officer, effective immediately. Mr. McGourlay has been with the Company for more than 25 years and has held senior roles in sales, customer operations, IT, technical support, product support and special …

NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 3% of the outstanding shares of Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”), today sent a letter to the Company's Board of Directors outlining several opportunities to close Avantor's significant valuation gap and unlock value for shareholders. The letter can be viewed and downloaded here. About Engine Capital Engine Capital LP is a value-oriented special situation.

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases, today reported corporate updates and financial results for the quarter ended June 30, 2025.